Literature DB >> 13908867

[The hirudin test, a micromethod for control of the prothrombin level in anticoagulant therapy].

R SCHMUTZLER, F MARKWARDT.   

Abstract

Entities:  

Keywords:  ANTICOAGULANTS/therapy; HIRUDIN/pharmacology; PROTHROMBIN TIME/pharmacology

Mesh：

Substances：

Year:  1962        PMID： 13908867     DOI： 10.1007/bf01481255

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  8 in total

1.  [The reaction between hirudin and thrombin].

Authors:  F MARKWARDT; P WALSMANN
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1958

2.  [The use of prothrombin determination with hirudin in the supervision of treatment with dicoumarol derivatives].

Authors:  F MARKWARDT; G WENZEL
Journal:  Blut       Date:  1961-04

3.  [Isolation and chemical characterization of hirudin].

Authors:  F MARKWARDT
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1957

4.  [Determination of thrombin by titration with hirudin].

Authors:  F MARKWARDT
Journal:  Arch Pharm Ber Dtsch Pharm Ges       Date:  1957-06

5.  [Quantitative determination of prothrombin by titration with hirudin].

Authors:  F MARKWARDT
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1958

6.  [Studies on the mechanism of the anticoagulant effect of hirudin].

Authors:  F MARKWARDT
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1956

7.  Prothrombin and accessory factors; clinical significance.

Authors:  P A OWREN
Journal:  Am J Med       Date:  1953-02       Impact factor: 4.965

8.  Experiments on a new clotting factor (factor VII).

Authors:  F KOLLER; A LOELIGER; F DUCKERT
Journal:  Acta Haematol       Date:  1951       Impact factor: 2.195
  8 in total
  1 in total

1.  [O(ON THE STANDARDIZATION OF HIRUDIN TRADE PREPARATIONS)].

Authors:  P WALSMANN
Journal:  Blut       Date:  1964-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.